Literature DB >> 21253052

Laboratory tests in the rheumatic disease.

S L Aaron.   

Abstract

Because the pathophysiologic relationship between laboratory and clinical abnormalities in many of the rheumatologic diseases is still not clearly understood, the use of the investigations dealt with in this article is based only upon statistics. The interpretation of these tests is therefore highly dependent on the result of the initial clinical assessment. Having accepted this limitation, however, the rheumatologist has available a number of powerful tools which may be used to diagnose, classify, or prognosticate.

Entities:  

Year:  1988        PMID: 21253052      PMCID: PMC2218748     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  24 in total

1.  Diseases associated with CPPD deposition disease.

Authors:  E B Hamilton
Journal:  Arthritis Rheum       Date:  1976 May-Jun

2.  A comparative study of technics for the detection of antibodies to native deoxyribonucleic acid.

Authors:  P Davis; A S Russell; J S Percy
Journal:  Am J Clin Pathol       Date:  1977-04       Impact factor: 2.493

3.  Reiter's disease and HL-A 27.

Authors:  D A Brewerton; M Caffrey; A Nicholls; D Walters; J K Oates; D C James
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

4.  Antinuclear antibodies in the investigation of rheumatic diseases.

Authors:  M J Fritzler
Journal:  Bull Rheum Dis       Date:  1985

5.  The role of the laboratory in rheumatology. Uric acid and the interpretation of hyperuricaemia.

Authors:  J T Scott
Journal:  Clin Rheum Dis       Date:  1983-04

6.  Polymyositis: its presentation, morbidity and mortality.

Authors:  R DeVere; W G Bradley
Journal:  Brain       Date:  1975-12       Impact factor: 13.501

7.  Antinuclear antibody with distinct specificity for polymyositis.

Authors:  J F Wolfe; E Adelstein; G C Sharp
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

9.  Antibodies to histones in drug-induced and idiopathic lupus erythematosus.

Authors:  M J Fritzler; E M Tan
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

10.  Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.

Authors:  M D Lockshin; M L Druzin; S Goei; T Qamar; M S Magid; L Jovanovic; M Ferenc
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

View more
  1 in total

1.  Plasma viscosity and erythrocyte sedimentation rate in inflammatory and non-inflammatory rheumatic disorders.

Authors:  G J Dinant; J W van Wersch; H S Goei The; J A Knottnerus
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.